Immunotherapy of pancreatic cancer with monoclonal antibody BW 494

This publication has 13 references indexed in Scilit:

• A monoclonal antibody with binding and inhibiting activity towards human pancreatic carcinoma cells
  Cancer Immunology, Immunotherapy, 1986
• OKT3 MONOCLONAL ANTIBODY PLASMA LEVELS DURING THERAPY AND THE SUBSEQUENT DEVELOPMENT OF HOST ANTIBODIES TO OKT3
  Transplantation, 1986
• Eradication of established human melanoma tumors in nude mice by antibody-directed effector cells.
  The Journal of Experimental Medicine, 1985
• Monoclonal anti-human tumor antibodies of six isotypes in cytotoxic reactions with human and murine effector cells
  Cellular Immunology, 1985
• Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.
  Proceedings of the National Academy of Sciences, 1985
• Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?
  Proceedings of the National Academy of Sciences, 1984
• Immunotherapy of Gastrointestinal Malignancies with a Murine IgG 2A Antibody*
  Published by S. Karger AG ,1984
• Monoclonal antibody-directed effector cells selectively lyse human melanoma cells in vitro and in vivo.
  Proceedings of the National Academy of Sciences, 1983
• A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II.
  Journal of Biological Chemistry, 1982
• IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.
  Proceedings of the National Academy of Sciences, 1982